Latest filing published 18 Jun 2025 for Maravai Lifesciences Holdings, INC., €167k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Murali Prahalad: trading record in brief
All filings by Murali Prahalad on record concern Maravai Lifesciences Holdings, Inc., in the capacity of board member. We count 9 filings; the first trade dates from 19 November 2020 and the latest from 16 June 2025.
Purchases make up the whole of the open-market record (1 purchase, €410k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 5 share grants.
Most recently, on 18 June 2025, the filings show a share grant worth €167k in Maravai Lifesciences Holdings, Inc. The clock since the last published purchase (25 November 2020) now reads 2,175 days. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Murali Prahalad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 89,139 shares@ US$2.1644.7% of flowClass A Common StockSEC:0001823239-25-000085:0
- 20,645 shares@ US$10.78100.0% of flowClass A Common StockSEC:0001823239-24-000078:0
- 24,000 shares0Class A Common StockSEC:0001823239-23-000062:0
- 3,000 shares0Class A Common StockSEC:0000899243-22-003853:0
- 4,271 shares0Class A Common StockSEC:0000899243-21-045775:0
5 of 5 declarations
